Nuformix (LSE:NFX) Accounts Payable : £0.19 Mil (As of Sep. 2022)

View and export this data going back to 2015. Start your Free Trial

What is Nuformix Accounts Payable?

Nuformix's Accounts Payable for the quarter that ended in Sep. 2022 was £0.19 Mil.

Nuformix's quarterly Accounts Payable declined from Sep. 2021 (£0.17 Mil) to Mar. 2022 (£0.01 Mil) but then increased from Mar. 2022 (£0.01 Mil) to Sep. 2022 (£0.19 Mil).

Nuformix's annual Accounts Payable declined from Mar. 2020 (£0.13 Mil) to Mar. 2021 (£0.10 Mil) and declined from Mar. 2021 (£0.10 Mil) to Mar. 2022 (£0.01 Mil).

Nuformix Accounts Payable Historical Data

The historical data trend for Nuformix's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix Accounts Payable Chart

Nuformix Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Accounts Payable

Get a 7-Day Free Trial

0.09

0.32

0.13

0.10

0.01

Nuformix Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23
Accounts Payable	Get a 7-Day Free Trial									0.10	0.17	0.01	0.19	0.27

Nuformix Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Nuformix Accounts Payable Related Terms

Thank you for viewing the detailed overview of Nuformix's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuformix (LSE:NFX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

1RT:Germany

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

https://www.nuformix.com

Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.